Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04864080 · ClinicalTrials.gov registry record · NA

Transdiagnostic Cognitive Biomarkers

A NA study of Depression and Pain, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT04864080 is a NA study of Depression and Pain that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 45 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04864080, a NA study of Depression and Pain, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.

Conditions Studied

Interventions

  • BEHAVIORAL Computer game/task
  • BEHAVIORAL Health surveys online

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2022-04-11
Est. Completion 2027-03-01
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT04864080

The ClinicalTrials.gov registry entry for NCT04864080 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Computer game/task is the first listed.

NCT04864080 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04864080 about?

NCT04864080 is a clinical study titled "Transdiagnostic Cognitive Biomarkers". The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitiv...

What is the current status of trial NCT04864080?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2022-04-11. Estimated completion is 2027-03-01.

What conditions does trial NCT04864080 study?

This clinical trial studies the following conditions: Depression, Pain.

What interventions are being tested in trial NCT04864080?

The interventions under investigation include: Computer game/task (BEHAVIORAL), Health surveys online (BEHAVIORAL).

Who is sponsoring clinical trial NCT04864080?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04864080 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.